Aden Mendoza (@adenmendoza_) 's Twitter Profile
Aden Mendoza

@adenmendoza_

PGY-0 @Dukeneurosurg | @DukeMedSchool '25 | @ucsdbiosciences MS '18, BS '17

ID: 1917258668141051904

calendar_today29-04-2025 16:44:32

0 Tweet

16 Followers

147 Following

Shawn Hervey-Jumper (@herveyjumper) 's Twitter Profile Photo

Congratulations to UCSF School of Medicine Mulki Mehari for publishing science.org/doi/epdf/10.11…. Despite the goal of maximizing enrollment of brain cancer patients in clinical trials, many studies fail to meet recruitment targets.

Congratulations to <a href="/UCSFMedicine/">UCSF School of Medicine</a>  <a href="/mehari_mulki/">Mulki Mehari</a> for publishing science.org/doi/epdf/10.11…. Despite the goal of maximizing enrollment of brain cancer patients in clinical trials, many studies fail to meet recruitment targets.
UCSF Neurosurgery (@neurosurgucsf) 's Twitter Profile Photo

New in Science Advances, Mulki Mehari, Annette Molinaro, PhD, Shawn Hervey-Jumper, and their colleagues present a new AI-based clinical trial enrollment tool that provides recommendations for personalized for each patient’s circumstances: science.org/doi/10.1126/sc… UCSF Helen Diller Family Comprehensive Cancer Ctr

New in <a href="/ScienceAdvances/">Science Advances</a>, <a href="/mehari_mulki/">Mulki Mehari</a>, Annette Molinaro, PhD, <a href="/HerveyJumper/">Shawn Hervey-Jumper</a>, and their colleagues present a new AI-based clinical trial enrollment tool that provides recommendations for personalized for each patient’s circumstances: science.org/doi/10.1126/sc…
<a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a>
Journal of Clinical Investigation (@jclinicalinvest) 's Twitter Profile Photo

In glioma, T cell immunotherapies are limited by the quantity of available T cells. Kirit Singh Peter Fecci Mustafa Khasraw (find me in BlueSky) & team address this challenge in preclinical models by peripheral injection of autologous T cells after pre-treatment with IL-7. Full report

In glioma, T cell immunotherapies are limited by the quantity of available T cells.

<a href="/KiritSingh/">Kirit Singh</a> <a href="/PeterFecci/">Peter Fecci</a> <a href="/MKhasraw/">Mustafa Khasraw (find me in BlueSky)</a> &amp; team address this challenge in preclinical models by peripheral injection of autologous T cells after pre-treatment with IL-7.

Full report